awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39255218-2251C161-5511-4257-98E7-0B5F87718C5C
Q39255218-2251C161-5511-4257-98E7-0B5F87718C5C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39255218-2251C161-5511-4257-98E7-0B5F87718C5C
Strategies for monitoring and combating resistance to combination kinase inhibitors for cancer therapy.
P2860
Q39255218-2251C161-5511-4257-98E7-0B5F87718C5C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39255218-2251C161-5511-4257-98E7-0B5F87718C5C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3a4057ecd1bb86321da419205b57f1c05eecca70
P2860
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition.